FMT in Gut aGVHD Treated
ConditionAcute-graft-versus-host Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10-60
SponsorThe First Affiliated Hospital of Soochow University
About this trial
With the stem cell transplanting increasing, patients which effected with gut GVHD were also increased. To evaluation the safety and efficacy of FMT for gut GVHD,patients with gut GVHD were recruited.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
gut GVHD
Disqualifiers
Age>60; or Age<10
Trial population
After stem cell transplantating , some patients suffered the gut GVHD were recuited
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Fecal microbiota
Biological/Vaccinefecal microbiota transplantation
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
times of stool
Change from stool times in a week
Time frame
24hours,48hours,72hours, 96hours,fifth day,sixth day, a weekSecondary outcomes
1
volume in milliliter of stool
Change from stool volume in a week
Time frame
24hours,48hours,72hours, 96hours,fifth day,sixth day, a weekSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov